Počet záznamů: 1
Proteomics of anti-cancer drugs
- 1.0328756 - ÚŽFG 2010 DE eng A - Abstrakt
Kovářová, Hana - Martinková, Jiřina - Hrabáková, Rita - Skalníková, Helena - Novák, Petr - Hajdůch, M. - Gadher, S. J.
Proteomics of anti-cancer drugs.
[Proteomika protirakovinových drog.]
FEBS Journal. Roč. 276, Supplement 1 (2009), s. 84-84. ISSN 1742-464X. E-ISSN 1742-4658.
[34th FEBS Congress. 04.07.2009-09.07.2009, Praha]
Grant CEP: GA MŠMT LC07017
Výzkumný záměr: CEZ:AV0Z50450515; CEZ:AV0Z50200510
Klíčová slova: proteomics * anti-cancer drugs * biomarkers
Kód oboru RIV: FD - Onkologie a hematologie
Clinical importance of biomarkers as a handle for monitoring therapeutics response is of growing importance. Our study is focused on monitoring molecular mechanisms of response to anti.cancer drugs at earlier time intervals to detect relevant proteins that are responsible fr primary changes in signalling networks that subsequently lead to irreversible anti-cancer processes.
Trvalý link: http://hdl.handle.net/11104/0174987
Počet záznamů: 1